Veterinary Medicine CAS 186826-86-8 Hydrochloride HCl Moxifloxacin

Product Details
Customization: Available
Varieties: Parasite Disease Prevention Medicine
Component: Animal
Still deciding? Get samples of US$ 50/kg
Request Sample
Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Registered Capital
10000000 RMB
Plant Area
101~500 square meters
  • Veterinary Medicine CAS 186826-86-8 Hydrochloride HCl Moxifloxacin
  • Veterinary Medicine CAS 186826-86-8 Hydrochloride HCl Moxifloxacin
  • Veterinary Medicine CAS 186826-86-8 Hydrochloride HCl Moxifloxacin
  • Veterinary Medicine CAS 186826-86-8 Hydrochloride HCl Moxifloxacin
  • Veterinary Medicine CAS 186826-86-8 Hydrochloride HCl Moxifloxacin
  • Veterinary Medicine CAS 186826-86-8 Hydrochloride HCl Moxifloxacin
Find Similar Products

Basic Info.

Model NO.
moxifloxacin
Type
The First Class
Pharmacodynamic Influential Factors
Animal Species
Storage Method
Prevent High or LowTemperature
Veterinary Reg. No.
09853
Product
Moxifloxacin HCl
CAS
186826-86-8
Mf
C21h25clfn3o4
Transport Package
Drum
Specification
99%
Trademark
HS
Origin
China
HS Code
2904201000
Production Capacity
100000

Product Description

Veterinary Medicine CAS 186826-86-8 Hydrochloride HCl Moxifloxacin

Product name: Moxifloxacin hydrochloride
Other name: AVALOX;BAY-12-8039;Moxifloxacin hydrochloride Solution, 1000ppm;Moxifloxacin and intermediates;Moxifloxacin HCl (Monohydrate);(1's,6's)-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride;Moxifloxacin HCl USP;1-cyclopropyl-6-fluoro-8-methoxy-7-((4aS,7aS)-octahydropyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
CAS: 186826-86-8
MF: C21H25ClFN3O4
MW: 437.8923032
EINECS: 641-756-7

Melting point: 324-325 °C
Storage Temp.: 2-8°C
Usage: Antibacterial


Description:

Moxifioxacin hydrochlodde is one of the two new fluoroquinolonecarboxylic acid antibiotics introduced in 1999 for the treatment of respiratory tract infections such as community-acquired pneumonia, acute exacerbations of bronchitis or acute sinusitis. Moxifloxacin can be synthesized through a 12 step sequence from the classical 4-quinolone-3-carboxylic acid template. Some advantages of Moxifloxacin over Ciprofloxacin, another of Bayer's launched quinolones, have been shown, i.e. an enhanced activity against Gram-positive bacteria (Streptococcus pneumoniae, Clostndium pneumoniae), a favorable pharmacokinetic profile (good tissue penetration and plasma concentrations above MICs) and a lack of phototoxicity (UVA irradiation).

Usage:

Moxifloxacin Hydrochloride is a fluoroquinolone antibiotic developed by Bayer Pharmaceuticals (Germany.) It can be used to treat community-acquired pneumonia caused by Staphylococcus aureus, baccilus, pneumococcus, mucositis Moraxella, and Klebsiella pneumoniae, acute chronic bronchitis attacks, and acute sinusitis. For the treatment of adult bacterial lung infections, paranasal sinus, skin, and abdominal cavity. Also used to treat community-acquired pneumonia, chronic bronchitis, urogenital infection, and acute sinusitis.


Veterinary Medicine CAS 186826-86-8 Hydrochloride HCl Moxifloxacin

What is Moxifloxacin Hydrochloride ?


Moxifloxacin is a kind of near white crystal powder chemical. Its molecular formula is C21H24FN3O4. Its molecular weight is 401.4314. Its melting point is 193-195 C. It is insoluble in water, slightly soluble in ethanol and almost insoluble in acetone. Moxifloxacin is a quinolone drug. It is mainly used to treat adults with upper and lower respiratory tract infections (> 18 years old), such as acute sinusitis, acute attack of chronic bronchitis, community acquired pneumonia, skin and soft tissue infections.
 

Function


Moxifloxacin can be used to treat social acquired pneumonia caused by Staphylococcus aureus, influenza bacilli, pneumococcus, acute attack of chronic bronchitis, acute sinusitis, etc. It belongs to the fourth generation of quinolone antibiotics and is a new generation of broad spectrum antibiotics. It has strong antimicrobial activity against common respiratory pathogens such as Streptococcus pneumoniae, Haemophilus, Morahan catarrhalis and some Staphylococcus aureus, especially Streptococcus pneumoniae. It is clinically used to treat acute sinus adenitis, acute exacerbation of chronic bronchitis) community acquired pneumonia, as well as non-complications of skin and soft tissue 

Veterinary Medicine CAS 186826-86-8 Hydrochloride HCl Moxifloxacin

Moxifloxacin hydrochloride Specification:

 
Analysis Test Specification Result
Description crystalline powder Conforms
Solubility soluble in water Conforms
PH 6.0~7.5 6.9
Solution clarity and color solution should be clear and colorless Conforms
Related substances 5'CMP 0.3%
Simple impurity
Total other impurity
0.01%
0.03%
0.10%
Chloride 0.05% Conforms
Ammonium 0.05% Conforms
Fe 0.01% Conforms
Phosphate 0.1% Conforms
Loss on drying ≤6.0% 1.3%
Heavy metals 0.002% Conforms
Arsenide 0.0001% Conforms
Bacterial Endotoxins 0.3EU/mg Conforms
Microbial Limit Conforms Conforms
Assay(on dried basis) ≥98.0% 98.8%
Veterinary Medicine CAS 186826-86-8 Hydrochloride HCl MoxifloxacinVeterinary Medicine CAS 186826-86-8 Hydrochloride HCl MoxifloxacinVeterinary Medicine CAS 186826-86-8 Hydrochloride HCl MoxifloxacinVeterinary Medicine CAS 186826-86-8 Hydrochloride HCl MoxifloxacinVeterinary Medicine CAS 186826-86-8 Hydrochloride HCl MoxifloxacinVeterinary Medicine CAS 186826-86-8 Hydrochloride HCl Moxifloxacin

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier